ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008

Wyngaarden List, Reportedly Six-Seven Names For NCI Director, Goes to White House This Week

November 11, 1988

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Howard Temin, 59, NCAB Member, Nobel Laureate, Dead

February 18, 1994